TESARO Announces Participation at Two Investor Conferences
Feb 21, 2017 21:15 pm UTC| Business
WALTHAM, Mass., Feb. 21, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are: The Raymond...
Mattersight to Present at the 29th Annual Roth Conference
Feb 21, 2017 21:15 pm UTC| Business
CHICAGO, Feb. 21, 2017 -- Mattersight Corporation (NASDAQ:MATR), the pioneer in personality-based software applications, today announced that the Company will attend the 29th Annual Roth Conference on March 12-15, 2017...
Sigma Labs Announces Completion of Public Offering and Gross Proceeds of Approximately $5.8 Million
Feb 21, 2017 21:15 pm UTC| Business
SANTA FE, N.M., Feb. 21, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced the closing of its previously...
Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer
Feb 21, 2017 21:10 pm UTC| Business
SAN RAMON, Calif., Feb. 21, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced that the Company’s...
Gladstone Land Announces Fourth Quarter and Year End 2016 Results
Feb 21, 2017 21:08 pm UTC| Business
MCLEAN, Va., Feb. 21, 2017 -- Gladstone Land Corporation (NASDAQ:LAND) (the “Company”) today reported financial results for the fourth quarter and year ended December31, 2016. A reconciliation of funds from operations...
Auris Medical Announces Closing of $10 Million Public Offering
Feb 21, 2017 21:07 pm UTC| Business
Zug, Switzerland, February 21, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced the...
Auris Medical Announces Closing of $10 Million Public Offering
Feb 21, 2017 21:07 pm UTC| Business
Zug, Switzerland, February 21, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced the...